About Atlas Genetics’
io® system

Our pioneering, flexible diagnostic instrument and disposable cartridge system is designed for decentralised laboratory, point-of–care and other near-patient settings. It provides a fast, easy-to-use and accurate affordable solution to screening for the presence of STIs and HAIs, where rapid diagnosis is essential for effective treatment and control.

Find out more

 

Validation of Novel Electrochemistry in a Combined Molecular & Immunoassay Point-of-Care Platform using Patient Samples: Application to Sexually Transmitted Diseases. As presented at ASM, May 2010. (Green, M. et al., 2010.)

With the dramatic increase in the incidence of Chlamydia and the rising number of cases of Syphilis and Gonorrhoea there is an unmet need for a Point-of-Care (PoC) platform capable of providing multiplexed test results based on both rapid molecular and immunoassay methods. To address this need Atlas Genetics have developed a PoC platform, the Velox™ system, based on highly sensitive electrochemical detection technology. We have developed molecular assays for Chlamydia and Gonorrhoea, and an immunoassay for Syphilis based on this platform, with the results for each in less than 30 minutes.

Access the full PDF publication, sign into "the Hub" now - click here

Get access to all the latest industry insight   SIGN-UP TO THE ATLAS GENETICS RESOURCE HUB

Contact us

Atlas Genetics
Derby Court 
Epsom Square 
White Horse Business Park 
Trowbridge, Wiltshire 
BA14 0XG 
United Kingdom 

 

+44 (0)1225 717930 
info@atlasgenetics.com

FIND US


logos

Follow us



Hear more about the ways that 
the Atlas Genetics io® can
assist you 

REQUEST MORE PRODUCT INFORMATION